SGM-201

N/A

Report date: 2022/08/24 20:00:31

NME

Base Information

Drug NameSGM-201

Drug Alias NameN/A

ClassificationOther

Mechanisms of ActionDiagnostic imaging enhancers

TargetsUpdating

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSurgimab Sas

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSurgimab Sas

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A

Related LinksN/A